Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Acquisitions (Details Textual)

v3.3.1.900
Note 2 - Acquisitions (Details Textual) - USD ($)
 3 Months Ended 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Developed Technology [Member]        
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life     18 years  
Trade Names [Member]        
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life     20 years  
Customer Relationships [Member]        
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life     4 years  
Cliniqa [Member]        
Revenue, Net $ 6,600,000   $ 10,100,000  
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest 900,000   400,000  
Amortization of Intangible Assets 700,000   1,300,000  
Fair Value Write-Up of Acquired Inventory 500,000   800,000  
Revenue, Net 120,907,000 $ 111,948,000 233,288,000 $ 220,425,000
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest 35,374,000 42,563,000 67,221,000 77,161,000
Amortization of Intangible Assets 7,361,000 6,858,000 14,767,000 12,586,000
Fair Value Write-Up of Acquired Inventory $ 1,245,000 $ 1,188,000 $ 2,357,000 $ 4,355,000